| editorial | Q871232 |
| scholarly article | Q13442814 |
| P50 | author | Sanjay Kalra | Q80639815 |
| P2093 | author name string | Rakesh Sahay | |
| Puneet Dhamija | |||
| P2860 | cites work | Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. | Q34628009 |
| Pioglitazone and bladder cancer: a population-based study of Taiwanese. | Q35688201 | ||
| The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 | ||
| Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study | Q36013549 | ||
| Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis | Q36247512 | ||
| Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study | Q36486802 | ||
| Pioglitazone and bladder cancer: a propensity score matched cohort study | Q36562522 | ||
| Pioglitazone and risk of bladder cancer: clarification of the design of the French study | Q43838222 | ||
| Safety and efficacy of low-dose pioglitazone (7.5 mg/day) vs. standard-dose pioglitazone (15 mg/day) in Japanese women with type 2 diabetes mellitus. | Q51497865 | ||
| Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes | Q85642529 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 370-372 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Indian Journal of Endocrinology and Metabolism | Q15816442 |
| P1476 | title | Pioglitazone: A prudent prescription | |
| P478 | volume | 17 |
Search more.